Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
Portfolio Pulse from
Merit Medical Systems has announced 12-month efficacy results for its WRAPSODY Cell-Impermeable Endoprosthesis (CIE) from the WAVE trial. The results will be presented at the Society of Interventional Radiology's 50th Annual Scientific Meeting in Nashville, with a podium presentation scheduled for March 30, 2025, during the late-breaking trials session.
March 25, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Positive 12-month efficacy data for the WRAPSODY endoprosthesis could demonstrate the company's innovative medical technology and potential market expansion in kidney access treatment.
Positive clinical trial results often boost investor confidence in medical technology companies by demonstrating product efficacy and potential market opportunity.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100